Found: 13
Select item for more details and to access through your institution.
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 593, doi. 10.1177/09612033231165151
- By:
- Publication type:
- Article
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 603, doi. 10.1177/09612033231164635
- By:
- Publication type:
- Article
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 612, doi. 10.1177/09612033231164637
- By:
- Publication type:
- Article
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 625, doi. 10.1177/09612033231160731
- By:
- Publication type:
- Article
Integrated analysis and clinical correlation analysis of hub genes, immune infiltration, and potential therapeutic agents related to lupus nephritis.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 633, doi. 10.1177/09612033231161587
- By:
- Publication type:
- Article
The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 644, doi. 10.1177/09612033231161961
- By:
- Publication type:
- Article
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 658, doi. 10.1177/09612033231163745
- By:
- Publication type:
- Article
Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 668, doi. 10.1177/09612033231164091
- By:
- Publication type:
- Article
The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 675, doi. 10.1177/09612033231164262
- By:
- Publication type:
- Article
Serum levels and significance of soluble B-cell maturation antigen in childhood-onset systemic lupus erythematosus with renal involvement.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 680, doi. 10.1177/09612033231164633
- By:
- Publication type:
- Article
A 5–year follow-up of pulmonary function tests in childhood-onset systemic lupus erythematosus: a single-center retrospective study.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 688, doi. 10.1177/09612033231163831
- By:
- Publication type:
- Article
Combined 13-valent pneumococcal conjugate and 23-valent pneumococcal polysaccharide vaccine regimens for adults with systemic lupus erythematosus: Does the sequence of pneumococcal vaccination affect immunogenicity responses? A single-center cohort study in Brazil.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 694, doi. 10.1177/09612033231153535
- By:
- Publication type:
- Article
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors.
- Published in:
- Lupus, 2023, v. 32, n. 5, p. 704, doi. 10.1177/09612033231166337
- By:
- Publication type:
- Article